Global Podophyllotoxin Market

Podophyllotoxin Comprehensive Study by Type (Purity 95%, Purity 98%, Other), Application (Chemical Reagents, Pharmaceutical Intermediates, Other) Players and Region - Global Market Outlook to 2026

Podophyllotoxin Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Podophyllotoxin Market Overview:
Podophyllotoxin (PPT), also known as podofilox, is the starting material for the semi-synthesis of the anti-cancer drugs etoposide, teniposide, and etopophos. These compounds have been used for the treatment of lung and testicular cancers as well as certain leukemias.

Growth Drivers
  • Increasing Numbers of Cancer Prevalence’s Worldwide

Roadblocks
  • The Total Synthesis of Podophyllotoxin Is an Expensive Process
  • Availability of the Compound from Natural Renewable Resources Is an Important Issue for Pharmaceutical Companies

Opportunities
  • Research & Development Activities
  • The Emerging Demand from Developing Countries


Competitive Landscape:

Some of the key players profiled in the report are Acros Organics (A Thermo Fisher Scientific Inc. Company) (United States), Toronto Research Chemicals Inc. (Canada), Pure Chemistry Scientific, Inc. (United States), Pfanstiehl Inc. (United States), SEQENS SAS (France), Merck KGaA (Germany), AdooQ BioScience LLC (United States) and Chemical Diversity (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Podophyllotoxin market by 2026.

What Can be Explored with the Podophyllotoxin Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Podophyllotoxin Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Podophyllotoxin
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Podophyllotoxin market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Podophyllotoxin market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Podophyllotoxin Manufacturers, Podophyllotoxin Traders/Distributors, Podophyllotoxin Importer/Exporter, Regulatory & Government Bodies, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Purity 95%
  • Purity 98%
  • Other
By Application
  • Chemical Reagents
  • Pharmaceutical Intermediates
  • Other
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Numbers of Cancer Prevalence’s Worldwide
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Podophyllotoxin, by Type, Application and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Podophyllotoxin (Value)
      • 5.2.1. Global Podophyllotoxin by: Type (Value)
        • 5.2.1.1. Purity 95%
        • 5.2.1.2. Purity 98%
        • 5.2.1.3. Other
      • 5.2.2. Global Podophyllotoxin by: Application (Value)
        • 5.2.2.1. Chemical Reagents
        • 5.2.2.2. Pharmaceutical Intermediates
        • 5.2.2.3. Other
      • 5.2.3. Global Podophyllotoxin Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Podophyllotoxin (Volume)
      • 5.3.1. Global Podophyllotoxin by: Type (Volume)
        • 5.3.1.1. Purity 95%
        • 5.3.1.2. Purity 98%
        • 5.3.1.3. Other
      • 5.3.2. Global Podophyllotoxin by: Application (Volume)
        • 5.3.2.1. Chemical Reagents
        • 5.3.2.2. Pharmaceutical Intermediates
        • 5.3.2.3. Other
      • 5.3.3. Global Podophyllotoxin Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Podophyllotoxin (Price)
      • 5.4.1. Global Podophyllotoxin by: Type (Price)
  • 6. Podophyllotoxin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Acros Organics (A Thermo Fisher Scientific Inc. Company) (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Toronto Research Chemicals Inc. (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pure Chemistry Scientific, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfanstiehl Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. SEQENS SAS (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck KGaA (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. AdooQ BioScience LLC (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Chemical Diversity (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Podophyllotoxin Sale, by Type, Application and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Podophyllotoxin (Value)
      • 7.2.1. Global Podophyllotoxin by: Type (Value)
        • 7.2.1.1. Purity 95%
        • 7.2.1.2. Purity 98%
        • 7.2.1.3. Other
      • 7.2.2. Global Podophyllotoxin by: Application (Value)
        • 7.2.2.1. Chemical Reagents
        • 7.2.2.2. Pharmaceutical Intermediates
        • 7.2.2.3. Other
      • 7.2.3. Global Podophyllotoxin Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Podophyllotoxin (Volume)
      • 7.3.1. Global Podophyllotoxin by: Type (Volume)
        • 7.3.1.1. Purity 95%
        • 7.3.1.2. Purity 98%
        • 7.3.1.3. Other
      • 7.3.2. Global Podophyllotoxin by: Application (Volume)
        • 7.3.2.1. Chemical Reagents
        • 7.3.2.2. Pharmaceutical Intermediates
        • 7.3.2.3. Other
      • 7.3.3. Global Podophyllotoxin Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Podophyllotoxin (Price)
      • 7.4.1. Global Podophyllotoxin by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Podophyllotoxin: by Type(USD Million)
  • Table 2. Podophyllotoxin Purity 95% , by Region USD Million (2015-2020)
  • Table 3. Podophyllotoxin Purity 98% , by Region USD Million (2015-2020)
  • Table 4. Podophyllotoxin Other , by Region USD Million (2015-2020)
  • Table 5. Podophyllotoxin: by Application(USD Million)
  • Table 6. Podophyllotoxin Chemical Reagents , by Region USD Million (2015-2020)
  • Table 7. Podophyllotoxin Pharmaceutical Intermediates , by Region USD Million (2015-2020)
  • Table 8. Podophyllotoxin Other , by Region USD Million (2015-2020)
  • Table 9. South America Podophyllotoxin, by Country USD Million (2015-2020)
  • Table 10. South America Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 11. South America Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 12. Brazil Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 13. Brazil Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 14. Argentina Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 15. Argentina Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 16. Rest of South America Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 17. Rest of South America Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 18. Asia Pacific Podophyllotoxin, by Country USD Million (2015-2020)
  • Table 19. Asia Pacific Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 20. Asia Pacific Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 21. China Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 22. China Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 23. Japan Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 24. Japan Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 25. India Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 26. India Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 27. South Korea Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 28. South Korea Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 29. Taiwan Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 30. Taiwan Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 31. Australia Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 32. Australia Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 35. Europe Podophyllotoxin, by Country USD Million (2015-2020)
  • Table 36. Europe Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 37. Europe Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 38. Germany Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 39. Germany Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 40. France Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 41. France Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 42. Italy Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 43. Italy Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 44. United Kingdom Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 45. United Kingdom Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 46. Netherlands Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 47. Netherlands Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 48. Rest of Europe Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 49. Rest of Europe Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 50. MEA Podophyllotoxin, by Country USD Million (2015-2020)
  • Table 51. MEA Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 52. MEA Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 53. Middle East Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 54. Middle East Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 55. Africa Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 56. Africa Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 57. North America Podophyllotoxin, by Country USD Million (2015-2020)
  • Table 58. North America Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 59. North America Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 60. United States Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 61. United States Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 62. Canada Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 63. Canada Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 64. Mexico Podophyllotoxin, by Type USD Million (2015-2020)
  • Table 65. Mexico Podophyllotoxin, by Application USD Million (2015-2020)
  • Table 66. Podophyllotoxin Sales: by Type(K Tons)
  • Table 67. Podophyllotoxin Sales Purity 95% , by Region K Tons (2015-2020)
  • Table 68. Podophyllotoxin Sales Purity 98% , by Region K Tons (2015-2020)
  • Table 69. Podophyllotoxin Sales Other , by Region K Tons (2015-2020)
  • Table 70. Podophyllotoxin Sales: by Application(K Tons)
  • Table 71. Podophyllotoxin Sales Chemical Reagents , by Region K Tons (2015-2020)
  • Table 72. Podophyllotoxin Sales Pharmaceutical Intermediates , by Region K Tons (2015-2020)
  • Table 73. Podophyllotoxin Sales Other , by Region K Tons (2015-2020)
  • Table 74. South America Podophyllotoxin Sales, by Country K Tons (2015-2020)
  • Table 75. South America Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 76. South America Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 77. Brazil Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 78. Brazil Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 79. Argentina Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 80. Argentina Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 81. Rest of South America Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 82. Rest of South America Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 83. Asia Pacific Podophyllotoxin Sales, by Country K Tons (2015-2020)
  • Table 84. Asia Pacific Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 85. Asia Pacific Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 86. China Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 87. China Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 88. Japan Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 89. Japan Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 90. India Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 91. India Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 92. South Korea Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 93. South Korea Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 94. Taiwan Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 95. Taiwan Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 96. Australia Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 97. Australia Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 98. Rest of Asia-Pacific Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 99. Rest of Asia-Pacific Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 100. Europe Podophyllotoxin Sales, by Country K Tons (2015-2020)
  • Table 101. Europe Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 102. Europe Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 103. Germany Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 104. Germany Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 105. France Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 106. France Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 107. Italy Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 108. Italy Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 109. United Kingdom Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 110. United Kingdom Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 111. Netherlands Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 112. Netherlands Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 113. Rest of Europe Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 114. Rest of Europe Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 115. MEA Podophyllotoxin Sales, by Country K Tons (2015-2020)
  • Table 116. MEA Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 117. MEA Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 118. Middle East Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 119. Middle East Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 120. Africa Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 121. Africa Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 122. North America Podophyllotoxin Sales, by Country K Tons (2015-2020)
  • Table 123. North America Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 124. North America Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 125. United States Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 126. United States Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 127. Canada Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 128. Canada Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 129. Mexico Podophyllotoxin Sales, by Type K Tons (2015-2020)
  • Table 130. Mexico Podophyllotoxin Sales, by Application K Tons (2015-2020)
  • Table 131. Podophyllotoxin: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Podophyllotoxin: by Type(USD Million)
  • Table 141. Podophyllotoxin Purity 95% , by Region USD Million (2021-2026)
  • Table 142. Podophyllotoxin Purity 98% , by Region USD Million (2021-2026)
  • Table 143. Podophyllotoxin Other , by Region USD Million (2021-2026)
  • Table 144. Podophyllotoxin: by Application(USD Million)
  • Table 145. Podophyllotoxin Chemical Reagents , by Region USD Million (2021-2026)
  • Table 146. Podophyllotoxin Pharmaceutical Intermediates , by Region USD Million (2021-2026)
  • Table 147. Podophyllotoxin Other , by Region USD Million (2021-2026)
  • Table 148. South America Podophyllotoxin, by Country USD Million (2021-2026)
  • Table 149. South America Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 150. South America Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 151. Brazil Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 152. Brazil Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 153. Argentina Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 154. Argentina Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 155. Rest of South America Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 156. Rest of South America Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 157. Asia Pacific Podophyllotoxin, by Country USD Million (2021-2026)
  • Table 158. Asia Pacific Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 159. Asia Pacific Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 160. China Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 161. China Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 162. Japan Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 163. Japan Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 164. India Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 165. India Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 166. South Korea Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 167. South Korea Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 168. Taiwan Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 169. Taiwan Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 170. Australia Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 171. Australia Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 172. Rest of Asia-Pacific Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 173. Rest of Asia-Pacific Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 174. Europe Podophyllotoxin, by Country USD Million (2021-2026)
  • Table 175. Europe Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 176. Europe Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 177. Germany Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 178. Germany Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 179. France Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 180. France Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 181. Italy Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 182. Italy Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 183. United Kingdom Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 184. United Kingdom Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 185. Netherlands Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 186. Netherlands Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 187. Rest of Europe Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 188. Rest of Europe Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 189. MEA Podophyllotoxin, by Country USD Million (2021-2026)
  • Table 190. MEA Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 191. MEA Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 192. Middle East Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 193. Middle East Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 194. Africa Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 195. Africa Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 196. North America Podophyllotoxin, by Country USD Million (2021-2026)
  • Table 197. North America Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 198. North America Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 199. United States Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 200. United States Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 201. Canada Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 202. Canada Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 203. Mexico Podophyllotoxin, by Type USD Million (2021-2026)
  • Table 204. Mexico Podophyllotoxin, by Application USD Million (2021-2026)
  • Table 205. Podophyllotoxin Sales: by Type(K Tons)
  • Table 206. Podophyllotoxin Sales Purity 95% , by Region K Tons (2021-2026)
  • Table 207. Podophyllotoxin Sales Purity 98% , by Region K Tons (2021-2026)
  • Table 208. Podophyllotoxin Sales Other , by Region K Tons (2021-2026)
  • Table 209. Podophyllotoxin Sales: by Application(K Tons)
  • Table 210. Podophyllotoxin Sales Chemical Reagents , by Region K Tons (2021-2026)
  • Table 211. Podophyllotoxin Sales Pharmaceutical Intermediates , by Region K Tons (2021-2026)
  • Table 212. Podophyllotoxin Sales Other , by Region K Tons (2021-2026)
  • Table 213. South America Podophyllotoxin Sales, by Country K Tons (2021-2026)
  • Table 214. South America Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 215. South America Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 216. Brazil Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 217. Brazil Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 218. Argentina Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 219. Argentina Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 220. Rest of South America Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 221. Rest of South America Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 222. Asia Pacific Podophyllotoxin Sales, by Country K Tons (2021-2026)
  • Table 223. Asia Pacific Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 224. Asia Pacific Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 225. China Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 226. China Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 227. Japan Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 228. Japan Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 229. India Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 230. India Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 231. South Korea Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 232. South Korea Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 233. Taiwan Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 234. Taiwan Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 235. Australia Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 236. Australia Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 237. Rest of Asia-Pacific Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 238. Rest of Asia-Pacific Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 239. Europe Podophyllotoxin Sales, by Country K Tons (2021-2026)
  • Table 240. Europe Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 241. Europe Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 242. Germany Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 243. Germany Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 244. France Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 245. France Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 246. Italy Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 247. Italy Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 248. United Kingdom Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 249. United Kingdom Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 250. Netherlands Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 251. Netherlands Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 252. Rest of Europe Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 253. Rest of Europe Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 254. MEA Podophyllotoxin Sales, by Country K Tons (2021-2026)
  • Table 255. MEA Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 256. MEA Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 257. Middle East Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 258. Middle East Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 259. Africa Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 260. Africa Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 261. North America Podophyllotoxin Sales, by Country K Tons (2021-2026)
  • Table 262. North America Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 263. North America Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 264. United States Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 265. United States Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 266. Canada Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 267. Canada Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 268. Mexico Podophyllotoxin Sales, by Type K Tons (2021-2026)
  • Table 269. Mexico Podophyllotoxin Sales, by Application K Tons (2021-2026)
  • Table 270. Podophyllotoxin: by Type(USD/Units)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Podophyllotoxin: by Type USD Million (2015-2020)
  • Figure 5. Global Podophyllotoxin: by Application USD Million (2015-2020)
  • Figure 6. South America Podophyllotoxin Share (%), by Country
  • Figure 7. Asia Pacific Podophyllotoxin Share (%), by Country
  • Figure 8. Europe Podophyllotoxin Share (%), by Country
  • Figure 9. MEA Podophyllotoxin Share (%), by Country
  • Figure 10. North America Podophyllotoxin Share (%), by Country
  • Figure 11. Global Podophyllotoxin: by Type K Tons (2015-2020)
  • Figure 12. Global Podophyllotoxin: by Application K Tons (2015-2020)
  • Figure 13. South America Podophyllotoxin Share (%), by Country
  • Figure 14. Asia Pacific Podophyllotoxin Share (%), by Country
  • Figure 15. Europe Podophyllotoxin Share (%), by Country
  • Figure 16. MEA Podophyllotoxin Share (%), by Country
  • Figure 17. North America Podophyllotoxin Share (%), by Country
  • Figure 18. Global Podophyllotoxin: by Type USD/Units (2015-2020)
  • Figure 19. Global Podophyllotoxin share by Players 2020 (%)
  • Figure 20. Global Podophyllotoxin share by Players (Top 3) 2020(%)
  • Figure 21. Global Podophyllotoxin share by Players (Top 5) 2020(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Acros Organics (A Thermo Fisher Scientific Inc. Company) (United States) Revenue, Net Income and Gross profit
  • Figure 24. Acros Organics (A Thermo Fisher Scientific Inc. Company) (United States) Revenue: by Geography 2020
  • Figure 25. Toronto Research Chemicals Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 26. Toronto Research Chemicals Inc. (Canada) Revenue: by Geography 2020
  • Figure 27. Pure Chemistry Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Pure Chemistry Scientific, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Pfanstiehl Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfanstiehl Inc. (United States) Revenue: by Geography 2020
  • Figure 31. SEQENS SAS (France) Revenue, Net Income and Gross profit
  • Figure 32. SEQENS SAS (France) Revenue: by Geography 2020
  • Figure 33. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Merck KGaA (Germany) Revenue: by Geography 2020
  • Figure 35. AdooQ BioScience LLC (United States) Revenue, Net Income and Gross profit
  • Figure 36. AdooQ BioScience LLC (United States) Revenue: by Geography 2020
  • Figure 37. Chemical Diversity (United States) Revenue, Net Income and Gross profit
  • Figure 38. Chemical Diversity (United States) Revenue: by Geography 2020
  • Figure 39. Global Podophyllotoxin: by Type USD Million (2021-2026)
  • Figure 40. Global Podophyllotoxin: by Application USD Million (2021-2026)
  • Figure 41. South America Podophyllotoxin Share (%), by Country
  • Figure 42. Asia Pacific Podophyllotoxin Share (%), by Country
  • Figure 43. Europe Podophyllotoxin Share (%), by Country
  • Figure 44. MEA Podophyllotoxin Share (%), by Country
  • Figure 45. North America Podophyllotoxin Share (%), by Country
  • Figure 46. Global Podophyllotoxin: by Type K Tons (2021-2026)
  • Figure 47. Global Podophyllotoxin: by Application K Tons (2021-2026)
  • Figure 48. South America Podophyllotoxin Share (%), by Country
  • Figure 49. Asia Pacific Podophyllotoxin Share (%), by Country
  • Figure 50. Europe Podophyllotoxin Share (%), by Country
  • Figure 51. MEA Podophyllotoxin Share (%), by Country
  • Figure 52. North America Podophyllotoxin Share (%), by Country
  • Figure 53. Global Podophyllotoxin: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Acros Organics (A Thermo Fisher Scientific Inc. Company) (United States)
  • Toronto Research Chemicals Inc. (Canada)
  • Pure Chemistry Scientific, Inc. (United States)
  • Pfanstiehl Inc. (United States)
  • SEQENS SAS (France)
  • Merck KGaA (Germany)
  • AdooQ BioScience LLC (United States)
  • Chemical Diversity (United States)
Select User Access Type

Key Highlights of Report


Dec 2021 240 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Podophyllotoxin Market Quantitative research analysis
Global Podophyllotoxin Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Podophyllotoxin market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Podophyllotoxin market are Acros Organics (A Thermo Fisher Scientific Inc. Company) (United States), Toronto Research Chemicals Inc. (Canada), Pure Chemistry Scientific, Inc. (United States), Pfanstiehl Inc. (United States), SEQENS SAS (France), Merck KGaA (Germany), AdooQ BioScience LLC (United States) and Chemical Diversity (United States), to name a few.

Know More About Global Podophyllotoxin Market Report?

Have a Query? Click Here

Other Related Reports

Mitogen Activated Protein Kinase 8 Comprehensive Study by Type (CC-90001, SR-3306, ER-358063, WBZ-4, Others), Application (Breast Cancer, Alzheimer's Disease, Acute Renal Failure, Liver Failure, Othe...
$ 3500
Viral Clearance Service Comprehensive Study by Application (Recombinant Proteins, Blood and Blood Products, Vaccines, Other), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Org...
$ 3650
Trypsin Comprehensive Study by Type (Cationic trypsin or Trypsin-1, Anionic trypsin or Trypsin-2, Mesotrypsin or Trypsin-3), Application (Biological Research, Medicines, Supplements, Others), Form (T...
$ 3450
Blood Cell Analyzer Comprehensive Study by Type (Semi-automated Biochemistry Analyzers, Fully Automated Biochemistry Analyzers), Application (Hospitals, Diagnostic Centers, Pharmaceutical Companies, ...
$ 3750
Synthetic Biology Comprehensive Study by Type (Core Products {Synthetic DNA, Synthetic Cells, Synthetic Genes, XNA and Chassis Organisms}, Enabling Products {DNA Synthesis and Oligonucleotide Synthes...
$ 3750
DNA Polymerase Comprehensive Study by Type (Prokaryotic DNA polymerase, Eukaryotic DNA polymerase), Application (DNA Cloning, SNP Analysis, Next Generation Sequencing Applications, Other), End-User (...
$ 3650